Nanosphere upgraded to Overweight from Neutral at Piper Jaffray

July 31, 2012

Piper Jaffray upgraded Nanosphere after its channel checks at the American Academy of Clinical Chemistry indicated meaningful activity since the company's Gram Positive test was approved. Piper doubled its price target for shares to $4 from $2.